Yik Jasper H N, Saxena Amit, Weigel Janet A, Weigel Paul H
Department of Biochemistry & Molecular Biology, The Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, USA.
J Biol Chem. 2002 Oct 25;277(43):40844-52. doi: 10.1074/jbc.M204780200. Epub 2002 Aug 8.
The hepatic asialoglycoprotein receptor (ASGP-R) internalizes desialylated glycoproteins via the clathrin-coated pit pathway and mediates their delivery to lysosomes for degradation. The human ASGP-R contains two subunits, H1 and H2. Cytoplasmic residues Cys(36) in H1, as well as Cys(54) and Cys(58) in H2 are palmitoylated (Zeng, F.-Y., and Weigel, P. H. (1996) J. Biol. Chem. 271, 32454). In order to study the function(s) of ASGP-R palmitoylation, we mutated these Cys residues to Ser and generated stably transfected SK-Hep-1 cell lines expressing either wild-type or nonpalmitoylated ASGP-Rs. Compared with wild-type ASGP-Rs, palmitoylation-defective ASGP-Rs showed normal ligand binding, intracellular distribution and trafficking patterns, and pH-induced dissociation profiles in vitro. However, continuous ASOR uptake, and the uptake of prebound cell surface ASOR were slower in cells expressing palmitoylation-defective ASGP-Rs than in cells expressing wild-type ASGP-Rs. Unlike native ASGP-Rs in hepatocytes or hepatoma cells, which mediate endocytosis via the clathrin-coated pit pathway and are almost completely inhibited by hypertonic medium, only approximately 40% of the ASOR uptake in SK-Hep-1 cells expressing wild-type ASGP-Rs was inhibited by hyperosmolarity. This result suggests the existence of an alternate nonclathrin-mediated internalization pathway, such as transcytosis, for the entry of ASGP-R.ASOR complexes into these cells. In contrast, ASOR uptake mediated by cells expressing palmitoylation-defective ASGP-Rs showed only a marginal difference under hypertonic conditions, indicating that most of the nonpalmitoylated ASGP-Rs were not internalized and processed normally through the clathrin-coated pit pathway. Furthermore, cells expressing wild-type ASGP-Rs were able to degrade the internalized ASOR, whereas ASOR dissociation was impaired and degradation was barely detectable in cells expressing nonpalmitoylated ASGP-Rs. We conclude that palmitoylation of the ASGP-R is required for its efficient endocytosis of ligand by the clathrin-dependent endocytic pathway and, in particular, for the proper dissociation and delivery of ligand to lysosomes.
肝脏去唾液酸糖蛋白受体(ASGP-R)通过网格蛋白包被小窝途径内化去唾液酸化糖蛋白,并介导其转运至溶酶体进行降解。人ASGP-R包含两个亚基,H1和H2。H1中的胞质残基Cys(36)以及H2中的Cys(54)和Cys(58)发生了棕榈酰化(曾,F.-Y.,和韦格尔,P. H.(1996年)《生物化学杂志》271, 32454)。为了研究ASGP-R棕榈酰化的功能,我们将这些半胱氨酸残基突变为丝氨酸,并生成了稳定转染的SK-Hep-1细胞系,该细胞系表达野生型或非棕榈酰化的ASGP-R。与野生型ASGP-R相比,棕榈酰化缺陷型ASGP-R表现出正常的配体结合、细胞内分布和运输模式,以及体外pH诱导的解离曲线。然而,在表达棕榈酰化缺陷型ASGP-R的细胞中,持续的ASOR摄取以及预先结合在细胞表面的ASOR的摄取比表达野生型ASGP-R的细胞要慢。与肝细胞或肝癌细胞中的天然ASGP-R不同,后者通过网格蛋白包被小窝途径介导内吞作用,并且几乎完全被高渗培养基抑制,在表达野生型ASGP-R的SK-Hep-1细胞中,只有约40%的ASOR摄取被高渗抑制。这一结果表明存在一种替代的非网格蛋白介导的内化途径,如转胞吞作用,用于ASGP-R-ASOR复合物进入这些细胞。相反,在高渗条件下,表达棕榈酰化缺陷型ASGP-R的细胞介导的ASOR摄取仅显示出微小差异,表明大多数非棕榈酰化的ASGP-R不能通过网格蛋白包被小窝途径正常内化和加工。此外,表达野生型ASGP-R的细胞能够降解内化的ASOR,而在表达非棕榈酰化ASGP-R的细胞中,ASOR解离受损且几乎检测不到降解。我们得出结论,ASGP-R的棕榈酰化对于其通过网格蛋白依赖性内吞途径有效内化配体是必需的,特别是对于配体正确解离并转运至溶酶体是必需的。